Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Emerging Coronaviruses: First Sars, Second Mers and Third Sars-Cov-2. Epidemiological Updates of Covid-19 Pubmed



Halaji M1, 2 ; Farahani A3 ; Ranjbar R4 ; Heiat M5 ; Dehkordi FS6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  4. 4. Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
  5. 5. Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, Iran
  6. 6. Halal Research Center of IRI, FDA, Tehran, Iran

Source: Infezioni in Medicina Published:2020


Abstract

Since December 2019, the emergence of the Severe Acute Respiratory Syndrome Coronavirus (SARSCoV-2) infection has been reported unexpectedly in Wuhan, China, With staggering infection speed across China and around the World. To date, seven known strains of HCoVs belonging to four genera (i.e., α−, β−, γ, and δ-CoV) have been recognized; the latest one has been identified as the SARS-CoV-2. Although the common transmission routes of SARS-CoV-2 is the respiratory tract, it seems that other routes such as the gastrointestinal tract may be effective for the entry of the virus in the body. Although there are no biological markers to predict the susceptibility of humans to COVID-19, several risk factors have been identified to predict the susceptibility of patients to COVID-19. Initial data revealed that males, pregnant Women, elderly, and underlying conditions predispose patients to higher morbidity or mortality and also might be at risk for a severe infection of COVID-19. There is a greater need to better understand the mechanisms and risk factors of transmission routes. To date, despite the Whole World effort to Review various aspects of SARSCoV-2, including epidemiology, clinical manifestations, diagnosis, and treatment options, there are still gaps in the knowledge of this disease and many issues remain unclear. Therefore, there is an urgent need for update data on SARS-CoV-2. Here, this study provide the current epidemiological status (transmission routes and risk of transmission, possible origins and source, mortality and morbidity risk, and geographical distribution) of the SARS-CoV-2 in the World in 2020. © 2020, EDIMES Edizioni Medico Scientifiche. All rights reserved.
Other Related Docs
10. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
12. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
15. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
26. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)
29. A Narrative Review of Covid-19: The New Pandemic Disease, Iranian Journal of Medical Sciences (2020)
41. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
44. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
47. Covid‑19’S Effect in Pregnancy and Vertical Transmission: A Systematic Review, International Journal of Preventive Medicine (2024)
48. New Corona Virus (Covid-19) Management in Pregnancy and Childbirth, Archives of Clinical Infectious Diseases (2020)